OliX Pharmaceuticals, Inc (KOSDAQ:226950)

OliX Pharmaceuticals Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 19, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	3,773,489	2,834,660	355,531	233,568	278,859	561,830
Market Cap Growth	373.74%	697.30%	52.22%	-16.24%	-50.37%	-17.52%
Enterprise Value	3,665,951	2,728,026	392,701	247,386	238,494	524,125
Last Close Price	186900.00	140400.00	19260.00	14580.00	20350.00	41000.00
PS Ratio	257.28	193.27	62.63	13.69	29.92	152.91
PB Ratio	25.14	18.89	19.25	4.64	4.21	28.95
P/TBV Ratio	25.77	19.36	22.02	4.92	4.48	34.29
EV/Sales Ratio	249.95	186.00	69.17	14.50	25.59	142.64
Debt / Equity Ratio	0.16	0.16	2.12	0.78	0.67	1.92
Net Debt / Equity Ratio	-0.73	-0.73	1.45	0.27	-0.27	-0.64
Net Debt / EBITDA Ratio	3.97	3.97	-0.95	-0.86	0.88	0.55
Net Debt / FCF Ratio	6.37	6.37	-0.64	-0.45	0.54	0.61
Asset Turnover	0.11	0.11	0.07	0.14	0.09	0.04
Inventory Turnover	0.70	0.70	0.49	0.28	0.40	0.51
Quick Ratio	6.51	6.51	0.45	4.71	1.59	1.24
Current Ratio	6.61	6.61	0.52	4.90	1.65	1.29
Return on Equity (ROE)	-18.68%	-18.68%	-118.18%	-32.78%	-65.68%	-90.11%
Return on Assets (ROA)	-14.05%	-14.05%	-22.20%	-9.65%	-12.75%	-18.33%
Return on Capital Employed (ROCE)	-17.20%	-17.20%	-75.10%	-18.90%	-24.00%	-52.30%
Earnings Yield	-0.42%	-0.56%	-11.44%	-8.18%	-6.99%	-5.29%
FCF Yield	-0.45%	-0.60%	-11.68%	-12.84%	-11.80%	-3.62%
Buyback Yield / Dilution	-16.84%	-16.84%	-16.73%	-5.30%	-0.13%	-4.06%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.